Stockreport

Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Intrinsic Value Is Potentially 98% Above Its Share Price [Yahoo! Finance]

Zentalis Pharmaceuticals, Inc. - common stock  (ZNTL) 
PDF Zentalis Pharmaceuticals' US$15.49 share price signals that it might be 50% undervalued The US$34.10 analyst price target for ZNTL is 11% more than our estimate of fa [Read more]